Zacks Small Cap Research on MSN

MTVA: Positive results for 48 mg cohort in phase 1b trial of DA-1726

By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort ...

Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Medical Dialogues

Telitacicept Matches Belimumab in Controlling Childhood Lupus, Study Finds

China: A prospective multicentre cohort study from China suggests that telitacicept, when used alongside standard of care ...